Striatal volume loss in HD as measured by MRI and the influence of CAG repeat

Background: Huntington’s disease (HD) is an autosomal dominant neurodegenerative disease that results from the expansion of a trinucleotide (CAG) repeat on chromosome 4. Progressive degeneration of the striatum is the pathologic hallmark of the disease. Little is known about the regional selectivity of the neurodegeneration and its relationship to the genetic expansion. Methods: The authors used high-resolution MRI to determine the relationship between the genetic expansion and the degree of striatal degeneration. Morphometric analyses of the striatum from high-resolution MR images from 27 subjects with HD were compared with those of 24 healthy control subjects. Results and conclusions: Striatal volumes were reduced in subjects with HD as compared with control subjects, in agreement with previously published reports. Left-sided volumes were smaller than right-sided volumes in subjects with HD; in healthy subjects, right-sided volumes were smaller. Finally, volume loss was significantly correlated with CAG repeat number. These results have potential implications for the design and assessment of therapeutic agents in the future.

[1]  S. Folstein,et al.  Putamen volume reduction on magnetic resonance imaging exceeds caudate changes in mild Huntington's disease , 1992, Annals of neurology.

[2]  N. Raz,et al.  Age, Gender, and Hemispheric Differences in Human Striatum: A Quantitative Review and New Data from in Vivo MRI Morphometry , 1995, Neurobiology of Learning and Memory.

[3]  G. Pearlson,et al.  Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. , 1996, Archives of neurology.

[4]  N. Makris,et al.  Gyri of the human neocortex: an MRI-based analysis of volume and variance. , 1998, Cerebral cortex.

[5]  J. Rapoport,et al.  Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. , 1996, Archives of general psychiatry.

[6]  G. Pearlson,et al.  Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[7]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[8]  Nikos Makris,et al.  Thalamic and amygdala–hippocampal volume reductions in first-degree relatives of patients with schizophrenia: an MRI-based morphometric analysis , 1999, Biological Psychiatry.

[9]  B. Brooker,et al.  Tables for clinicians to use to convert WAIS-R short forms , 1986 .

[10]  O. Suchowersky,et al.  Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. , 1996, Annals of neurology.

[11]  D. Kennedy,et al.  The human brain age 7-11 years: a volumetric analysis based on magnetic resonance images. , 1996, Cerebral cortex.

[12]  G. Pearlson,et al.  Longitudinal change in basal ganglia volume in patients with Huntington's disease , 1997, Neurology.

[13]  J. Cummings,et al.  Huntington's disease. , 1997, The Psychiatric clinics of North America.

[14]  B R Rosen,et al.  1H NMR spectroscopy studies of Huntington's disease , 1998, Neurology.

[15]  M. MacDonald,et al.  CAG repeat number governs the development rate of pathology in Huntington's disease , 1997, Annals of neurology.

[16]  O. Suchowersky,et al.  Relationship between trinucliotide repeats and neuropathological changes in Huntington's diease , 1996, Annals of neurology.

[17]  Glenn D. Rosen,et al.  Planum temporale asymmetry, reappraisal since Geschwind and Levitsky , 1987, Neuropsychologia.

[18]  B. Peterson,et al.  Reduced basal ganglia volumes in Tourette's syndrome using three‐dimensional reconstruction techniques from magnetic resonance images , 1993, Neurology.

[19]  M. MacDonald,et al.  Huntington's disease CAG trinucleotide repeats in pathologically confirmed post-mortem brains , 1994, Neurobiology of Disease.

[20]  K. Kieburtz,et al.  Functional decline in Huntington's disease , 1995, Movement disorders : official journal of the Movement Disorder Society.

[21]  E. Chee,et al.  Volumetric MRI changes in basal ganglia of children with Tourette's syndrome , 1993, Neurology.

[22]  D. Eidelberg,et al.  [11C]Raclopride‐PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat length , 1998, Annals of neurology.

[23]  M. MacDonald,et al.  The Genetic Defect Causing Huntington’s Disease: Repeated in Other Contexts? , 1997, Molecular medicine.

[24]  D. Kennedy,et al.  The young adult human brain: an MRI-based morphometric analysis. , 1994, Cerebral cortex.

[25]  J. Brandt,et al.  Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at‐risk persons , 1994, Neurology.

[26]  B. G. Jenkins,et al.  Laterality, somatotopy and reproducibility of the basal ganglia and motor cortex during motor tasks 1 1 Published on the World Wide Web on 28 August 2000. , 2000, Brain Research.